Price alert —
Sign in to get a one-time email the moment AMGN crosses your price. Free accounts included.
Sign in / create a free accountAmgen Inc. is a healthcare company listed in the US.
AMGN last traded at $366.29, down 1.4% on the day; that's in the middle part of its 52-week range ($320.52–$391.29). Right now it's trading close to its recent average, with no strong stretch in either direction.
Earnings reports are the biggest scheduled catalysts to keep an eye on, and day to day, watch whether it holds above or slips below its recent average.
A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.
On the latest daily bar, momentum sits mid-range (RSI 58), the trend is quiet (ADX 15), and volume is about normal (1.1×). On the business side, revenue is growing 6% year over year and the business keeps about 20 cents of every sales dollar as free cash.
Latest-bar indicator readings behind the grade — display-only, they don't move the letter.
Company fundamentals for context — display-only, they don't move the grade.
Our cash-flow model pegs fair value near $169.63 (fair range $170–$292); today's price sits 112% above that estimate. The model's verdict is “Overvalued” and accounting quality screens as Weak. Model estimates only — do your own due diligence.
- ✓ Gross margin 71% (pricing power)
- ✓ Net margin 21%
- ⚠ Debt exceeds cash
- ⚠ Quick ratio 0.85 (fragile)
- ⚠ Debt/equity 9.46 (fragile)
- ⚠ Negative retained earnings
Price implies ~15% growth (vs trailing rev yoy). Model estimate — do your own due diligence.
AMGN is a $192.6 billion company, priced at 25× last year's earnings.